Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery |
| |
| Authors: | Muhip Kanko Sadan Yavuz Can Duman Tulay Hosten Emin Oner Turan Berki |
| |
| Affiliation: | (1) Department of Cardiovascular Surgery, Kocaeli University Medical Faculty, 41380 Kocaeli, Turkey;(2) Department of Biochemistry, Canakkale Onsekiz Mart University Medical Faculty, 17100 Canakkale, Turkey;(3) Department of Anaesthesiology, Kocaeli University Medical Faculty, 41380 Kocaeli, Turkey |
| |
| Abstract: | Background Various types of markers have been used so far in order to reveal myocardial perfusion defect. However, these markers usually appear in the necrosis phase or in the late stage. Having been the focus of various investigations recently, ischemia-modified albumin (IMA) is helpful in establishing diagnosis in the early stages of ischemia, before necrosis develops. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
